Research report: Obesity and lymphoma: from pathobiology to clinical outcomes
A review links obesity with varied lymphoma risks, biological changes and treatment outcomes while emphasizing that clinical findings remain heterogeneous ...
A review links obesity with varied lymphoma risks, biological changes and treatment outcomes while emphasizing that clinical findings remain heterogeneous ...
A retrospective Chinese cohort found similar 3-year survival with oral and intravenous melphalan conditioning, but different engraftment and toxicity patterns.
An observational study of 89 patients found that elevated homocystine 42 hours after high-dose methotrexate was associated with kidney injury, ...
A previously healthy 12-year-old girl walked into a clinic with a two-month history of persistent left-sided headache, progressive swelling around ...
A new MD Anderson study finds that pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T cells determine ...
Brentuximab vedotin has transformed the outlook for patients with CD30-positive lymphomas, but the antibody-drug conjugate carries a neurological price that ...
The clinical case for expanding access to CAR T-cell therapy in Brazil rests on a substantial body of evidence demonstrating ...
A new hypothesis review argues that chemotherapy-curable cancers inherit their extraordinary drug sensitivity from healthy, transient precursor cells engaged in ...
Uruguay has launched Latin America's first fully academic, point-of-care CAR T-cell program for children with leukemia, treating five patients free ...
A 44-year-old man's classical Hodgkin lymphoma encased his aortic arch, tunneled through his C7–T1 neural foramina, and invaded his T1 ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine